Skip to main content

Advertisement

SpringerLink
Log in

Role of Ursodeoxycholic Acid in Prevention of Methotrexate-induced Liver Toxicity

  • Original Paper
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Aim Methotrexate (MTX)-induced hepatotoxicity restricts the clinical use of this immunosuppressive drug. In this study, our aim was to research the role of oxidative stress in the hepatic toxicity of MTX and the protective effect of ursodeoxycholic acid (UDCA) in this setting. Methods Wistar type rats (n = 32) were divided into four groups; group-1 as the MTX + UDCA, group-2 as the MTX, group-3 as the UDCA, group-4 as the saline-receiving groups. The MTX + UDCA and MTX groups of rats received 50 mg/kg of UDCA administered orally; whilst physiological saline was administered orally to the MTX and saline groups and continued for the next 6 days. On the second day of the study, the MTX + UDCA and MTX groups had a single intraperitoneal dose of MTX of 20 mg/kg. The UDCA and saline groups also received similar volumes of physiological saline intraperitoneally. On the sixth day, serum samples were collected and analyzed for ALT, alkaline phosphatase (ALP) and gamma glutamyl transpeptidase (GGT) and homogenated liver tissues were examined for reactive oxygen metabolites (ROM); luminol, lucigenin, lipid peroxygenation product malondialdehyde (MDA) and glutathione (GSH) levels. Results In the MTX group, serum ALT, ALP, GGT and tissue ROM levels were higher and GSH level was lower. On the histopathological examination, hepatocellular necrosis was clearly more evident in the MTX group than the MTX + UDCA group. Conclusions UDCA treatment protects against MTX-induced liver toxicity. Histopathologically hepatocyte necrosis can be prevented by UDCA treatment, indicating clearly the hepatoprotective effect of this agent on MTX-induced liver injury.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  1. Friis H, Andreasen PB (1992) Drug-induced hepatic injury: an analysis of 1,100 cases reported to the Danish Committee on Adverse Drug Reactions between 1978 and 1987. J Intern Med 232:133–138

    Article  PubMed  CAS  Google Scholar 

  2. Farrel GC (1994) Drug-induced liver disease. Edinburg, Churchill Livingstone

    Google Scholar 

  3. Hersh EM, Wong VG, Henderson ES, Freireich EJ (1966) Hepatotoxic effects of methotrexate. Cancer 19:600–606

    Article  PubMed  CAS  Google Scholar 

  4. Naldi L, Griffiths CE (2005) Traditional therapies in the management of moderate to severe chronic plaque psoriasis: an assessment of the benefits and risks. Br J Dermatol 152:597–615

    Article  PubMed  CAS  Google Scholar 

  5. Wu JJ, Schiff KR (2004) Sarcoidosis. Am Fam Physician 70:312–322

    PubMed  Google Scholar 

  6. Feagan BG, Alfadhli A (2004) Methotrexate in inflammatory bowel disease. Gastroenterol Clin North Am 33:407–420

    Article  PubMed  Google Scholar 

  7. Langford CA (2001) Management of systemic vasculitis. Best Pract Res Clin Rheumatol 15:281–297

    Article  PubMed  CAS  Google Scholar 

  8. Tsurusawa M, Saeki K, Fujimoto T (1997) Differential induction of apoptosis on human lymphoblastic leukemia Nalm-6 and Molt-4 cells by various antitumor drugs. Int J Hematol 66:79–88

    Article  PubMed  CAS  Google Scholar 

  9. Kremer JM, Alarcon GS, Lightfoot RW Jr, Willkens RF, Furst DE, Williams HJ, Dent PB, Weinblatt ME (1994) Methotrexate for rheumatoid arthritis: suggested guidelines for monitoring liver toxicity. Am Coll Rheumatol Arthritis Rheum 37:316–328

    CAS  Google Scholar 

  10. Walker TM, Rhodes PC, Westmoreland C (2000) The differential cytotoxicity of methotrexate in rat hepatocyte monolayer and spheroid cultures. Toxicol In Vitro 14:475–485

    Article  PubMed  CAS  Google Scholar 

  11. Gawkrodger DJ (1997) Current management of psoriasis. J Dermatol Treat 8:27–55

    Article  Google Scholar 

  12. Roenigk HH Jr, Auerbach R, Maibach HI, Weinstein G, Lebwohl M (1998) Methotrexate in psoriasis: consensus conference. J Am Acad Dermatol 38:478–485

    Article  PubMed  Google Scholar 

  13. Kamen BA, Nylen PA, Camitta BM, Bertino JR (1981) Methotrexate accumulation and folate depletion in cells as a possible mechanism of chronic toxicity to the drug. Br J Haematol 49:355–360

    PubMed  CAS  Google Scholar 

  14. Vogel WH, Snyder R, Schulman MP (1963) The inhibition of dehydrogenases by folic acid and several of its analogs. Biochem Biophys Res Commun 10:97–101

    Article  PubMed  CAS  Google Scholar 

  15. ter Borg EJ, Seldenrijk CA, Timmer R (1996) Liver cirrhosis due to methotrexate in a patient with rheumatoid arthritis. Neth J Med 49:244–246

    Article  PubMed  CAS  Google Scholar 

  16. Videla LA, Correa L, Rivera M, Sir T (1993) Zymosan-induced luminol-amplified chemiluminescence of whole blood phagocytes in experimental and human hyperthyroidism. Free Radic Biol Med 14:669–675

    Article  PubMed  CAS  Google Scholar 

  17. Van Dyke K, Patel S, Vallyathan V (2003) Lucigenin chemiluminescence assay as an adjunctive tool for assessment of various stages of inflammation: a study of quiescent inflammatory cells. J Biosci 28:115–119

    Article  PubMed  Google Scholar 

  18. Lucas M, Solano F (1992) Coelenterazine is a superoxide anion-sensitive chemiluminescent probe: its usefulness in the assay of respiratory burst in neutrophils. Anal Biochem 206:273–277

    Article  PubMed  CAS  Google Scholar 

  19. Rodrigues CM, Fan G, Wong PY, Kren BT, Steer CJ (1998) Ursodeoxycholic acid may inhibit deoxycholic acid-induced apoptosis by modulating mitochondrial transmembrane potential and reactive oxygen species production. Mol Med 4:165–178

    Article  PubMed  CAS  Google Scholar 

  20. Yamazaki K, Suzuki K, Nakamura A, Sato S, Lindor KD, Batts KP, Tarara JE, Kephart GM, Kita H, Gleich GJ (1999) Ursodeoxycholic acid inhibits eosinophil degranulation in patients with primary biliary cirrhosis. Hepatology 30:71–78

    Article  PubMed  CAS  Google Scholar 

  21. Davies GR, Simmonds NJ, Stevens TR, Grandison A, Blake DR, Rampton DS (1992) Mucosal reactive oxygen metabolite production in duodenal ulcer disease. Gut 33:1467–1472

    Article  PubMed  CAS  Google Scholar 

  22. Oktar BK, Coskun T, Bozkurt A, Yegen BC, Yuksel M, Haklar G, Bilsel S, Aksungar FB, Cetinel U, Granger DN, Kurtel H (2000) Endothelin-1-induced PMN infiltration and mucosal dysfunction in the rat small intestine. Am J Physiol Gastrointest Liver Physiol 279:483–491

    Google Scholar 

  23. Haklar G, Sayin-Ozveri E, Yuksel M, Aktan AO, Yalcin AS (2001) Different kinds of reactive oxygen and nitrogen species were detected in colon and breast tumors. Cancer Lett 165:219–224

    Article  PubMed  CAS  Google Scholar 

  24. Yagi K (1984) Assay for blood plasma or serum. Methods Enzymol 105:328–331

    PubMed  CAS  Google Scholar 

  25. Beutler E (1975) Glutathione in red blood cell metabolism. A manual of biochemical methods. Grune & Stratton, New York, pp 112–114

  26. Vonen B, Morland J (1984) Isolated rat hepatocytes in suspension: potential hepatotoxic effects of six different drugs. Arch Toxicol 56:33–37

    Article  PubMed  CAS  Google Scholar 

  27. Neuman MG, Cameron RG, Haber JA, Katz GG, Malkiewicz IM, Shear NH (1999) Inducers of cytochrome P450 2E1 enhance methotrexate-induced hepatocytoxicity. Clin Biochem 32:519–536

    Article  PubMed  CAS  Google Scholar 

  28. Morgan SL, Baggott JE, Vaughn WH, Young PK, Austin JV, Krumdieck CL, Alarcon GS (1990) The effect of folic acid supplementation on the toxicity of low-dose methotrexate in patients with rheumatoid arthritis. Arthritis Rheum 33:9–18

    Article  PubMed  CAS  Google Scholar 

  29. Ortiz Z, Shea B, Suarez-Almazor ME, Moher D, Wells GA, Tugwell P (1998) The efficacy of folic acid and folinic acid in reducing methotrexate gastrointestinal toxicity in rheumatoid arthritis. A metaanalysis of randomized controlled trials. J Rheumatol 25:36–43

    PubMed  CAS  Google Scholar 

  30. Morgan SL, Baggott JE, Vaughn WH, Young PK, Austin JV, Krumdieck CL, Alarcon GS (1990) The effect of folic acid supplementation on the toxicity of low-dose methotrexate in patients with rheumatoid arthritis. Arthritis Rheum 33:9–18

    Article  PubMed  CAS  Google Scholar 

  31. Ortiz Z, Shea B, Suarez-Almazor ME, Moher D, Wells GA, Tugwell P (1998) The efficacy of folic acid and folinic acid in reducing methotrexate gastrointestinal toxicity in rheumatoid arthritis. A metaanalysis of randomized controlled trials. J Rheumatol 25:36–43

    PubMed  CAS  Google Scholar 

  32. Rodrigues CM, Fan G, Ma X, Kren BT, Steer CJ (1998) A novel role for ursodeoxycholic acid in inhibiting apoptosis by modulating mitochondrial membrane perturbation. J Clin Invest 101:2790–2799

    Article  PubMed  CAS  Google Scholar 

  33. Calmus Y, Gane P, Rouger P, Poupon R (1990) Hepatic expression of class I and class II major histocompatibility complex molecules in primary biliary cirrhosis: effect of ursodeoxycholic acid. Hepatology 11:12–15

    Article  PubMed  CAS  Google Scholar 

  34. Terasaki S, Nakanuma Y, Ogino H, Unoura M, Kobayashi K (1991) Hepatocellular and biliary expression of HLA antigens in primary biliary cirrhosis before and after ursodeoxycholic acid therapy. Am J Gastroenterol 86:1194–1199

    PubMed  CAS  Google Scholar 

  35. Zhang JG, Zhong LF, Zhang M, Xia YX (1992) Protection effects of procaine on oxidative stress and toxicities of renal cortical slices from rats caused by cisplatin in vitro. Arch Toxicol 66:354–358

    Article  PubMed  CAS  Google Scholar 

  36. Parks DA, Granger DN (1988) Ischemia-reperfusion injury: a radical view. Hepatology 8:680–682

    Article  PubMed  CAS  Google Scholar 

  37. Sullivan GW, Sarembock IJ, Linden J (2000) The role of inflammation in vascular diseases. J Leukoc Biol 67:591–602

    PubMed  CAS  Google Scholar 

  38. Hall PD, Jenner MA, Ahern MJ (1991) Hepatotoxicity in a rat model caused by orally administered methotrexate. Hepatology 14:906–910

    Article  PubMed  CAS  Google Scholar 

  39. Sies H (1991) Oxidative stress: from basic research to clinical application. Am J Med 91:31–38

    Article  Google Scholar 

  40. Kaplowitz N (2000) Mechanisms of liver cell injury. J Hepatol 32:39–47

    Article  PubMed  CAS  Google Scholar 

  41. Meister A (1988) Glutathione. In: Arias IM, Jakoby WB, Popper H, et al (ed) The liver. biology and pathobiology, 2nd edn. Raven Press, New York, p 401

  42. Kaplowitz N, Tsukamoto H (1996) Oxidative stress and liver disease. Prog Liver Dis 14:131–159

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Gastroenterology, Kocaeli University Medical Faculty, Kocaeli, Turkey

    Suleyman Uraz, Cem Aygun, Omer Senturk & Sadettin Hulagu

  2. Department of Gastroenterology, School of Medicine, Marmara University, Tophanelioglu Cad, No:13/15, 34662, Altunizade/Istanbul, Turkey

    Veysel Tahan, Erol Avsar & Nurdan Tozun

  3. Institute of Gastroenterology, Marmara University, Istanbul, Turkey

    Fatih Eren

  4. Department of Biochemistry, School of Medicine, Marmara University, Istanbul, Turkey

    Goksenin Unluguzel, Meral Yuksel & Goncagul Haklar

  5. Department of Pathology, School of Medicine, Marmara University, Istanbul, Turkey

    Cigdem Celikel

Authors
  1. Suleyman Uraz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Veysel Tahan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Cem Aygun
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Fatih Eren
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Goksenin Unluguzel
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Meral Yuksel
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Omer Senturk
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Erol Avsar
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Goncagul Haklar
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Cigdem Celikel
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Sadettin Hulagu
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Nurdan Tozun
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Veysel Tahan.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Uraz, S., Tahan, V., Aygun, C. et al. Role of Ursodeoxycholic Acid in Prevention of Methotrexate-induced Liver Toxicity. Dig Dis Sci 53, 1071–1077 (2008). https://doi.org/10.1007/s10620-007-9949-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-007-9949-3

Keywords

Search

Navigation